PGNY — Progyny, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1551306 ·
Last close
$28.51
Market Cap
$2.23B
52W High
$28.57
52W Low
$16.10
ADV30
1,508,463
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 328,504,000 | 83,071,000 | 35,379,000 | 24,232,000 | 698,337,000 | 131,607,000 | 258,993,000 |
| Dec 2025 | 318,403,000 | 76,881,000 | 15,222,000 | 12,485,000 | 742,435,000 | 112,238,000 | 226,391,000 |
| Sep 2025 | 313,346,000 | 72,835,000 | 21,527,000 | 13,864,000 | 795,227,000 | 133,982,000 | 235,223,000 |
| Jun 2025 | 332,874,000 | 78,973,000 | 24,358,000 | 17,112,000 | 760,950,000 | 132,506,000 | 245,928,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$210,192,000
Investing CF
$-159,013,000
Financing CF
$-99,362,000
CapEx
$-18,410,000
Dividends Paid
—
Buybacks
$-81,657,000
EPS Diluted TTM
$0.65
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$202,827,000
Inventory
—
Receivables
$220,287,000
ST Investments
$197,858,000
EBIT TTM
$85,277,000
Pretax Income TTM
$95,432,000
Interest Exp TTM
—
Analysts
11
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,293,127,040
EBITDA
$109,509,000
Free Cash Flow
$200,213,248
Enterprise Value
$2,035,424,896
Total Cash
$225,111,008
Total Debt
$27,280,000
Shares Out
78,332,370
Trailing EPS
$0.77
Book Value
$5.66
ROE
14.9%
ROA
9.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,288,661,000 | 85,277,000 | 58,520,000 | 742,435,000 | 226,391,000 | — | 210,192,000 |
| Dec 2024 | 1,167,221,000 | 67,455,000 | 54,336,000 | 607,102,000 | 185,040,000 | — | 179,105,000 |
| Dec 2023 | 1,088,598,000 | 62,184,000 | 62,037,000 | 756,620,000 | 203,191,000 | — | 188,814,000 |
| Dec 2022 | 786,913,000 | 23,341,000 | 30,358,000 | 542,986,000 | 166,018,000 | — | 80,395,000 |
TTM Snapshot
Revenues TTM
$895,171,000
NetIncome TTM
$56,326,000
OpCashFlow TTM
$0
Assets (Latest)
$607,102,000
Forward EPS
$2.21
Max Pain — expiry 2026-11-20
max pain strike: $20.00 · spot: $28.43 · call oi: 2,581 · put oi: 101Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| WGS | GeneDx Holdings Corp. | $2.07B | $69.82 | — |
| SGRY | Surgery Partners, Inc. | $2.07B | $15.82 | — |
| SEM | SELECT MEDICAL HOLDINGS CORP | $2.05B | $16.50 | — |
| MD | Pediatrix Medical Group, Inc. | $2.03B | $24.68 | — |
| AGL | agilon health, inc. | $1.99B | $119.25 | — |
News headlines (Yahoo Finance, 1h cache)
3 Value Stocks That Fall Short
2026-06-29 11:14 · Yahoo
What Does the Sale of Progyny Shares by the CFO Mean for Investors?
2026-06-25 17:25 · Yahoo
1 Russell 2000 Stock for Long-Term Investors and 2 We Turn Down
2026-06-19 14:36 · Yahoo
What Progyny (PGNY)'s Governance Shift And $200 Million Buyback Mean For Shareholders
2026-06-10 14:08 · Yahoo
Progyny (PGNY) Authorizes $200M Share Repurchase Program
2026-06-04 16:51 · Yahoo
Conservative Guidance Weighed on Progyny (PGNY) Amid Strong Demand and Solid Execution
2026-06-04 14:21 · Yahoo
3 Cash-Heavy Stocks That Concern Us
2026-06-02 11:01 · Yahoo
A Progyny (PGNY) Insider Sold 5,500 Shares for $137,000
2026-05-31 15:22 · Yahoo
New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System
2026-05-28 13:04 · Yahoo
Progyny, Inc. Announces Share Repurchase Program
2026-05-26 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.